about
Convergence of mortality rates among patients on antiretroviral therapy in South Africa and North AmericaImproving health outcomes through concurrent HIV program scale-up and health system development in Rwanda: 20 years of experiencePerformance-based financing for improving HIV/AIDS service delivery: a systematic reviewTransitioning to Country Ownership of HIV Programs in RwandaTrends in and correlates of CD4+ cell count at antiretroviral therapy initiation after changes in national ART guidelines in Rwanda.Hepatitis C virus and HIV co-infection among pregnant women in RwandaA smartphone dongle for diagnosis of infectious diseases at the point of care.Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.Prevalence of hepatitis B and C infection in persons living with HIV enrolled in care in Rwanda.Rwanda 20 years on: investing in lifeDeterminants of circumcision and willingness to be circumcised by Rwandan men, 2010Assessing cost and technical efficiency of HIV prevention interventions in sub-Saharan Africa: the ORPHEA study design and methodsUnder-two child mortality according to maternal HIV status in Rwanda: assessing outcomes within the National PMTCT Program.Design, testing, and scale-up of medical devices for global health: negative pressure wound therapy and non-surgical male circumcision in Rwanda.HIV-free survival among nine- to 24-month-old children born to HIV-positive mothers in the Rwandan national PMTCT programme: a community-based household survey.Validating the Children's Depression Inventory in the context of RwandaOperating Characteristics of a Tuberculosis Screening Tool for People Living with HIV in Out-Patient HIV Care and Treatment Services, Rwanda.Mortality along the continuum of HIV care in Rwanda: a model-based analysis."Waiting for DAAs": A retrospective chart review of patients with untreated hepatitis C in Rwanda.Prevalence and risk factors for cervical cancer and pre-cancerous lesions in Rwanda.The Prevalence of Syphilis Infection and Its Associated Factors in the General Population of Rwanda: A National Household-Based SurveyTRACnet Internet and Short Message Service Technology Improves Time to Antiretroviral Therapy Initiation Among HIV-infected Infants in Rwanda.Estimation of the size of the female sex worker population in Rwanda using three different methods.Shared learning in an interconnected world: innovations to advance global health equityIntegration of comprehensive women's health programmes into health systems: cervical cancer prevention, care and control in Rwanda.A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans.Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission.High retention among HIV-infected children in Rwanda during scale-up and decentralization of HIV care and treatment programs, 2004 to 2010.Implementation and Operational Research: Evolution of Couples' Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice.Writing skills enhancement for public health professionals in RwandaCapacity building for oncology programmes in sub-Saharan Africa: the Rwanda experience.Programmatic Implications of Acute and Early HIV Infection.Mobile health applications for HIV prevention and care in Africa.Causes of hospital admission among people living with HIV worldwide: a systematic review and meta-analysis.Household survey of HIV incidence in Rwanda: a national observational cohort study.Phased implementation of spaced clinic visits for stable HIV-positive patients in Rwanda to support Treat All.Successive introduction of four new vaccines in Rwanda: High coverage and rapid scale up of Rwanda's expanded immunization program from 2009 to 2013.Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis.Accelerating initiation of antiretroviral therapy.Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis.
P50
Q21034185-A00EED15-EAB9-43BE-AEC1-214F1BF0406FQ26824742-34DDE3C4-83D6-4094-8674-B6CD37B064B9Q28359606-B98BBE1A-30E8-42E9-BEAD-3F41D9DB0652Q30382104-32891428-2581-415A-91A7-B1B66A0B04CBQ30388278-8360C159-596F-49B1-959A-051ABFCEF14EQ30398982-F9087856-0899-411C-9824-D5F6CE417DBBQ33442772-D8369C6E-EC4B-4C49-BA8B-9142C5260AC0Q33603586-59570B29-AFA7-42B4-B5D9-8EC5C33F882DQ33630346-AFD8AE5A-D5DE-43D3-883A-ED3F594B30DBQ34121092-7D64536F-E5F8-4FD5-BFBF-207909507244Q34160503-0F1B28D1-3F85-43C3-AAFD-DCFA4F3D93B3Q34659438-801EABC9-4E33-489D-B77D-ADB7ED02569FQ35548335-06F2B7E5-79B5-4770-A985-4FD4CAE33F6EQ35655257-905A4961-E2A9-46FD-BB8E-FCA1161387F3Q35800191-07179A06-8785-468F-9930-67A0031A268DQ35929609-BA69250A-90EB-49FA-90BF-29644F5C49BBQ36148542-0AEBF9EC-5FCB-4830-AE43-98E533FE7256Q36209055-AAD6EF40-9745-4F94-8AE8-AC967A2250AEQ36316465-B8A3BCE1-9403-4FA1-9232-8BCC9C76C5CDQ36326481-8003E1F4-2B9A-4DEF-9793-021D59AB575BQ36792771-4A429903-4045-463B-8B06-34A1C28387BCQ37047817-FD06B74C-7A0C-45DF-A93D-54BE96AC7DB5Q37062102-498E00DA-18F9-493E-A3BE-06144C7A69A3Q37153091-92F3F230-F91C-42C0-A45C-97A3F9932785Q37214456-7084FC3C-83CE-4E25-9604-EEE97BACF822Q37305526-BABE76C5-8570-4B20-A6F9-B2C10E679D11Q37312739-B50706B3-886B-4E15-A4F4-15C1610CF036Q37343714-1256727F-018B-41C4-83F2-549CFA20F0DFQ37722615-849048AB-8BB5-472C-8025-DE1C09EBCE12Q37742004-D91956B8-33E1-4E1F-A3B6-65D7E588D80AQ38387891-99B24E1E-E848-4BCA-945B-2D28E0F6CDD4Q38574468-0169127E-EAA3-443F-BD10-CAB0CFAF04E0Q38583482-7EAA1F73-075C-46D8-9C29-9BE7394CC058Q38596060-5B5EC5F4-8843-463A-988E-D29D7B817B43Q38628382-E32C1E2B-3087-41C0-B96F-E3E0E68E1859Q38647754-328717D0-91CC-47E8-B7D5-6FEEF1AF3033Q38679500-3C563C2F-3E66-4C95-A70B-445141615269Q38961883-9F854842-7CED-4491-ABA5-FFF1A8152756Q39008201-EAF21C86-D5C0-4BBC-857E-C9F8A16AAB97Q39120016-7B8944A3-D5E3-44D8-B388-3A1034405CB3
P50
name
Sabin Nsanzimana
@ast
Sabin Nsanzimana
@en
Sabin Nsanzimana
@es
Sabin Nsanzimana
@nl
type
label
Sabin Nsanzimana
@ast
Sabin Nsanzimana
@en
Sabin Nsanzimana
@es
Sabin Nsanzimana
@nl
prefLabel
Sabin Nsanzimana
@ast
Sabin Nsanzimana
@en
Sabin Nsanzimana
@es
Sabin Nsanzimana
@nl